In addition, miRNA‐618 directly targets metadherin mRNA to suppress the malignant phenotype of osteosarcoma cells by reducing phosphatase and tensin homolog (PTEN)/protein kinase B (AKT) pathway signaling.20 The gene discussed is AKT1; the disease is osteosarcoma.